🇺🇸 FDA
Pipeline program

Placebo - Film coated tablet for oral use, atrasentan

CEXV811A12301

Phase 3 small_molecule active

Quick answer

Placebo - Film coated tablet for oral use, atrasentan for Immunoglobulin A Nephropathy (IgAN) is a Phase 3 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).

Program details

Company
Novartis Ophthalmics Europe
Indication
Immunoglobulin A Nephropathy (IgAN)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials